Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Drug Metabolism Letters|February 4, 2012
Loxapine P-glycoprotein interactions in vitroAndrea Reed, Keith Huie, Elke S Perloff, et al.Therapeutic Drug Monitoring|June 18, 2014
Effect of smoking on the pharmacokinetics of inhaled loxapineLori H Takahashi, Keith Huie, Daniel A Spyker, et al.Bioorganic & Medicinal Chemistry|January 23, 2003
Relationships between structure, antibacterial activity, serum stability, pharmacokinetics and efficacy in 3-(heteroarylthio)cephems. Discovery of RWJ-333441 (MC-04,546)Tomasz Glinka, Keith Huie, Aesop Cho, et al.Antimicrobial Agents and Chemotherapy|May 23, 2003
Prodrugs of cephalosporin RWJ-333441 (MC-04,546) with improved aqueous solubilityScott J Hecker, Trevor Calkins, Mary E Price, et al.Bioanalysis|November 30, 2010
Validation of HPLC-MS/MS methods for analysis of loxapine, amoxapine, 7-OH-loxapine, 8-OH-loxapine and loxapine N-oxide in human plasmaJennifer S D Zimmer, Shane R Needham, Chad D Christianson, et al.Bioorganic & Medicinal Chemistry Letters|November 19, 2003
The relationship between physicochemical properties, in vitro activity and pharmacokinetic profiles of analogues of diamine-containing efflux pump inhibitorsWilliam J Watkins, Yakira Landaverry, Roger Léger, et al.Scientific Reports|July 30, 2024
JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humansAnne M Fourie, Xiaoli Cheng, Leon Chang, et al.Pageof 1